SBMBX
Price
$12.42
Change
-$0.00 (-0.00%)
Updated
Oct 8 closing price
Net Assets
1.01M
TRNEX
Price
$43.12
Change
+$0.09 (+0.21%)
Updated
Oct 8 closing price
Net Assets
2.48B
Interact to see
Advertisement

SBMBX vs TRNEX

Header iconSBMBX vs TRNEX Comparison
Open Charts SBMBX vs TRNEXBanner chart's image
Saratoga Energy & Basic Materials A
Price$12.42
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.01M
T. Rowe Price New Era I
Price$43.12
Change+$0.09 (+0.21%)
VolumeN/A
Net Assets2.48B
SBMBX vs TRNEX Comparison Chart in %
View a ticker or compare two or three
VS
SBMBX vs. TRNEX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBMBX is a Buy and TRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.48B vs. SBMBX (1.01M). TRNEX pays higher dividends than SBMBX: TRNEX (2.01) vs SBMBX (0.81). SBMBX was incepted earlier than TRNEX: SBMBX (28 years) vs TRNEX (10 years). SBMBX (3.81) is less costly to investors than TRNEX (0.57). SBMBX is a more actively managed with annual turnover of: 47.00 vs. TRNEX (24.30). SBMBX has a lower initial minimum investment than TRNEX: SBMBX (250) vs TRNEX (500000). TRNEX annual gain was more profitable for investors over the last year : 5.99 vs. SBMBX (-2.49). SBMBX return over 5 years is better than : 82.51 vs. TRNEX (66.67).
SBMBXTRNEXSBMBX / TRNEX
Total Expense Ratio3.810.57668%
Annual Report Gross Expense Ratio3.810.57668%
Fund Existence28 years10 years-
Gain YTD7.53215.95347%
Front Load6%N/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01M2.48B0%
Annual Yield % from dividends0.812.0140%
Returns for 1 year-2.495.99-41%
Returns for 3 years16.5620.2582%
Returns for 5 years82.5166.67124%
Returns for 10 years14.64N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSCX48.98N/A
N/A
BlackRock Health Sciences Opps Inv C
RDCCX8.77N/A
N/A
Columbia Disciplined Value C
BRZAX13.61N/A
N/A
BlackRock Sust Aware Adg Intl Eq Inv A
OBSOX27.62N/A
N/A
Oberweis Small-Cap Opportunities
HLMVX37.97N/A
N/A
Harding Loevner Global Equity Inst